Introduction
Cystic fibrosis (CF) is not widely regarded as a cause of intrauterine death. About 15% of all CF patients present with meconium ileus in the early postnatal period, and nearly 50% are classified as complicated because of an associated volvulus, intestinal atresia and perforation with peritonitis. 1 Volvulus is the most ominous complication in this setting with potentially devastating consequences. 2 Meconium ileus, volvulus and intestinal perforation are known to occur in utero, but data on pregnancy outcomes are scarce for fetuses affected with CF. A commonly proposed concept suggests that intestinal vascular incidents lead to atresia or demise in young fetuses, whereas inducing premature labor and birth later in pregnancy. 3 The current literature on the intrauterine course of intestinal obstructions, however, provides little information about the role of CF in fatal outcomes, suggesting that CF is not routinely looked for at autopsy studies of stillborn fetuses. Recent epidemiological surveys of autopsy findings in stillbirth do not specifically address the possibility of CF in the rare instances where fetal death has been attributed to intestinal complications. To illustrate the importance of excluding CF in these instances, we describe a case of late intrauterine death associated with malrotation and volvulus in a fetus affected with CF.
Case report CF was diagnosed by sweat test in a 4-year-old girl who had been followed by independent practitioners for failure to thrive and protracted respiratory infections. Genetic testing of the CFTR gene identified her as compound heterozygous carrier of the mutations p.Gln39X and p.Asn1303Lys. Subsequent analysis of the parents confirmed that the mutations were located on different alleles.
An extended family history revealed that 2 years after the birth of the index patient, her mother had lost a female baby at 38 weeks of gestation following intrauterine fetal demise. At autopsy, malrotation of the duodenum and the colon, as well as a jejunoileal volvulus with extended hemorrhagic infarction of the small bowel, were described. Death was attributed to cardiovascular failure and shock. No early CF-related organ manifestations such as intestinal calcifications or focal biliary cirrhosis were described and no further examinations were performed at that time.
After the diagnosis of CF had been established in the older sister, DNA was extracted from paraffin-embedded, formalin-fixed lung tissue of the fetus using the QIAMP DNeasy Tissue kit (Qiagen, Basel, Switzerland). Subsequent application of the CF v3 genotyping assay for assessing the p.Asn1303Lys mutation (Celera Diagnostics, Alameda), and PCR amplification of CFTR exon 2 and bidirectional DNA sequencing for the p.Gln39X mutation confirmed that this child was also a compound heterozygous carrier of the same two CFTR mutations that had previously been identified in her older sister.
Discussion
This report illustrates that CF should be suspected in intrauterine deaths occurring during the second and third trimester following an abdominal incident. Whole-blood or cell-rich tissue specimens should be preserved and genetic testing for CF considered.
The relevant autopsy findings included malrotation and volvulus with subsequent strangulation. Timing of normal gut rotation in the first trimester of pregnancy, when the intestine is partially obliterated and meconium has not yet been formed, is consistent with the observation that CF does not seem to increase the risk of malrotation. 4 Malrotation may, therefore, have independently predisposed to volvulus in the present case. However, there is ample evidence that CF itself can cause intrauterine gut obstruction and volvulus.
Before the introduction of genetic testing in the 1980s, prenatal diagnosis of CF relied on ultrasonographic signs of gut obstruction and ischemia and on abnormally low activities of various intestinal enzymes in the amniotic fluid. 5 Although the prevalence of CF in fetuses with such abnormal intra-abdominal findings hardly exceeds 20%, the relative risk of having CF may be increased more than 300-fold in Caucasian cohorts. 6 Signs of obstruction and ischemia include bowel distension, ascites, calcifications, hyperechoic bowel and cystic masses. Calcifications may be located in the peritoneal serosa resulting from meconium peritonitis, but they are more commonly found intramurally in CF, 7 presumably indicating areas of ischemia owing to marked bowel distension and focal volvulus. Serosal calcifications, in contrast, seem to be less prevalent than in non-CF fetuses with meconium peritonitis. It is believed that digestive enzymes, especially lipases, play an important role in the pathogenesis of meconium peritonitis, and that the low enzyme levels in CF fetuses thus cause less serosal damage. 7 Hyperechoic bowel is an unspecific finding of the second trimester that can occur as a normal variant or in association with intrauterine infection, aneuploidy, CF and other entities. The prevalence of CF in fetuses with hyperechoic bowel was found to be 2 to 7% in Caucasian cohorts. Intrauterine mortality in CF fetuses with hyperechoic bowel or meconium peritonitis is close to zero. 8, 9 It is, therefore, most likely from extended intestinal ischemia that fetal death in CF may result. Volvulus is not uncommon in CF with complicated meconium ileus, presenting alone or in association with intestinal atresia in 17 to 35% of all cases with meconium ileus. 10, 11 It has been suggested that volvulus in CF results from hyperperistaltic twisting of the proximal bowel in an attempt to overcome distal obstruction caused by inspissated meconium. 12 Case reports suggest that midgut volvuli presenting late in pregnancy bear a significant risk of intrauterine mortality. 3 By analogy to the present case, massive hemorrhagic infarction and necrosis of extended parts of the gut have been described. The possibility of CF, however, was not debated. 13 In conclusion, we presume that CF was not a coincidental finding in the present case. This is supported by data from the literature suggesting that meconium ileus promotes intestinal volvulus, which in turn can cause fetal demise. Genetic testing for CF should be considered if intrauterine death is attributed to volvulus in late pregnancy.
